nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—coronary artery disease—type 2 diabetes mellitus	0.51	1	CtDrD
Ticagrelor—CYP3A4—type 2 diabetes mellitus	0.136	1	CbGaD
Ticagrelor—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0302	0.133	CbGbCtD
Ticagrelor—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0269	0.118	CbGbCtD
Ticagrelor—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0195	0.0854	CbGbCtD
Ticagrelor—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0181	0.0794	CbGbCtD
Ticagrelor—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0161	0.0708	CbGbCtD
Ticagrelor—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0148	0.0648	CbGbCtD
Ticagrelor—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0134	0.0587	CbGbCtD
Ticagrelor—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0129	0.0566	CbGbCtD
Ticagrelor—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0117	0.0512	CbGbCtD
Ticagrelor—ABCB1—Glyburide—type 2 diabetes mellitus	0.00997	0.0437	CbGbCtD
Ticagrelor—ABCB1—Losartan—type 2 diabetes mellitus	0.00912	0.04	CbGbCtD
Ticagrelor—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00884	0.0388	CbGbCtD
Ticagrelor—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00848	0.0372	CbGbCtD
Ticagrelor—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00848	0.0372	CbGbCtD
Ticagrelor—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00802	0.0352	CbGbCtD
Ticagrelor—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00597	0.0262	CbGbCtD
Ticagrelor—CYP3A4—Losartan—type 2 diabetes mellitus	0.00546	0.024	CbGbCtD
Ticagrelor—P2RY12—artery—type 2 diabetes mellitus	0.000594	0.546	CbGeAlD
Ticagrelor—P2RY12—cardiovascular system—type 2 diabetes mellitus	0.000206	0.19	CbGeAlD
Ticagrelor—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	8.51e-05	0.000869	CcSEcCtD
Ticagrelor—Dyspepsia—Glyburide—type 2 diabetes mellitus	8.51e-05	0.000869	CcSEcCtD
Ticagrelor—Skin disorder—Gliclazide—type 2 diabetes mellitus	8.43e-05	0.000861	CcSEcCtD
Ticagrelor—Cough—Orlistat—type 2 diabetes mellitus	8.43e-05	0.00086	CcSEcCtD
Ticagrelor—Asthenia—Glimepiride—type 2 diabetes mellitus	8.41e-05	0.000859	CcSEcCtD
Ticagrelor—Malnutrition—Irbesartan—type 2 diabetes mellitus	8.4e-05	0.000857	CcSEcCtD
Ticagrelor—Asthenia—Sitagliptin—type 2 diabetes mellitus	8.38e-05	0.000856	CcSEcCtD
Ticagrelor—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	8.36e-05	0.000853	CcSEcCtD
Ticagrelor—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	8.36e-05	0.000853	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	8.35e-05	0.000852	CcSEcCtD
Ticagrelor—Chest pain—Valsartan—type 2 diabetes mellitus	8.32e-05	0.000849	CcSEcCtD
Ticagrelor—Dizziness—Glipizide—type 2 diabetes mellitus	8.31e-05	0.000848	CcSEcCtD
Ticagrelor—Pruritus—Glimepiride—type 2 diabetes mellitus	8.29e-05	0.000847	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	8.26e-05	0.000843	CcSEcCtD
Ticagrelor—Angiopathy—Losartan—type 2 diabetes mellitus	8.24e-05	0.000841	CcSEcCtD
Ticagrelor—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	8.23e-05	0.00084	CcSEcCtD
Ticagrelor—Chest pain—Orlistat—type 2 diabetes mellitus	8.22e-05	0.000839	CcSEcCtD
Ticagrelor—Epistaxis—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000835	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	8.17e-05	0.000833	CcSEcCtD
Ticagrelor—Hypotension—Gliclazide—type 2 diabetes mellitus	8.11e-05	0.000828	CcSEcCtD
Ticagrelor—Diarrhoea—Glimepiride—type 2 diabetes mellitus	8.02e-05	0.000819	CcSEcCtD
Ticagrelor—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	8e-05	0.000816	CcSEcCtD
Ticagrelor—Vomiting—Glipizide—type 2 diabetes mellitus	7.99e-05	0.000815	CcSEcCtD
Ticagrelor—Syncope—Metformin—type 2 diabetes mellitus	7.98e-05	0.000815	CcSEcCtD
Ticagrelor—Feeling abnormal—Glyburide—type 2 diabetes mellitus	7.97e-05	0.000813	CcSEcCtD
Ticagrelor—Dizziness—Pioglitazone—type 2 diabetes mellitus	7.96e-05	0.000812	CcSEcCtD
Ticagrelor—Rash—Glipizide—type 2 diabetes mellitus	7.92e-05	0.000808	CcSEcCtD
Ticagrelor—Dermatitis—Glipizide—type 2 diabetes mellitus	7.91e-05	0.000808	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	7.91e-05	0.000807	CcSEcCtD
Ticagrelor—Headache—Glipizide—type 2 diabetes mellitus	7.87e-05	0.000803	CcSEcCtD
Ticagrelor—Shock—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000801	CcSEcCtD
Ticagrelor—Loss of consciousness—Metformin—type 2 diabetes mellitus	7.82e-05	0.000798	CcSEcCtD
Ticagrelor—Nervous system disorder—Valsartan—type 2 diabetes mellitus	7.82e-05	0.000798	CcSEcCtD
Ticagrelor—Paraesthesia—Gliclazide—type 2 diabetes mellitus	7.8e-05	0.000796	CcSEcCtD
Ticagrelor—Dizziness—Glimepiride—type 2 diabetes mellitus	7.75e-05	0.000791	CcSEcCtD
Ticagrelor—Skin disorder—Valsartan—type 2 diabetes mellitus	7.75e-05	0.000791	CcSEcCtD
Ticagrelor—Dyspnoea—Gliclazide—type 2 diabetes mellitus	7.74e-05	0.00079	CcSEcCtD
Ticagrelor—Nervous system disorder—Orlistat—type 2 diabetes mellitus	7.73e-05	0.000789	CcSEcCtD
Ticagrelor—Dizziness—Sitagliptin—type 2 diabetes mellitus	7.73e-05	0.000789	CcSEcCtD
Ticagrelor—Hypertension—Metformin—type 2 diabetes mellitus	7.68e-05	0.000784	CcSEcCtD
Ticagrelor—Angioedema—Irbesartan—type 2 diabetes mellitus	7.67e-05	0.000783	CcSEcCtD
Ticagrelor—Oedema peripheral—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000783	CcSEcCtD
Ticagrelor—Skin disorder—Orlistat—type 2 diabetes mellitus	7.66e-05	0.000781	CcSEcCtD
Ticagrelor—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	7.65e-05	0.000781	CcSEcCtD
Ticagrelor—Back pain—Losartan—type 2 diabetes mellitus	7.65e-05	0.00078	CcSEcCtD
Ticagrelor—Abdominal pain—Glyburide—type 2 diabetes mellitus	7.64e-05	0.00078	CcSEcCtD
Ticagrelor—Dyspepsia—Gliclazide—type 2 diabetes mellitus	7.64e-05	0.00078	CcSEcCtD
Ticagrelor—Asthenia—Bromocriptine—type 2 diabetes mellitus	7.59e-05	0.000775	CcSEcCtD
Ticagrelor—Chest pain—Metformin—type 2 diabetes mellitus	7.58e-05	0.000773	CcSEcCtD
Ticagrelor—Vertigo—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.00077	CcSEcCtD
Ticagrelor—Headache—Pioglitazone—type 2 diabetes mellitus	7.54e-05	0.00077	CcSEcCtD
Ticagrelor—Syncope—Irbesartan—type 2 diabetes mellitus	7.53e-05	0.000769	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	7.52e-05	0.000768	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	7.5e-05	0.000765	CcSEcCtD
Ticagrelor—Fatigue—Gliclazide—type 2 diabetes mellitus	7.48e-05	0.000764	CcSEcCtD
Ticagrelor—Nausea—Glipizide—type 2 diabetes mellitus	7.46e-05	0.000762	CcSEcCtD
Ticagrelor—Vomiting—Glimepiride—type 2 diabetes mellitus	7.45e-05	0.000761	CcSEcCtD
Ticagrelor—Hypotension—Valsartan—type 2 diabetes mellitus	7.45e-05	0.000761	CcSEcCtD
Ticagrelor—Vomiting—Sitagliptin—type 2 diabetes mellitus	7.43e-05	0.000758	CcSEcCtD
Ticagrelor—Constipation—Gliclazide—type 2 diabetes mellitus	7.42e-05	0.000758	CcSEcCtD
Ticagrelor—Rash—Glimepiride—type 2 diabetes mellitus	7.39e-05	0.000754	CcSEcCtD
Ticagrelor—Dermatitis—Glimepiride—type 2 diabetes mellitus	7.38e-05	0.000754	CcSEcCtD
Ticagrelor—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	7.38e-05	0.000753	CcSEcCtD
Ticagrelor—Rash—Sitagliptin—type 2 diabetes mellitus	7.37e-05	0.000752	CcSEcCtD
Ticagrelor—Dermatitis—Sitagliptin—type 2 diabetes mellitus	7.36e-05	0.000751	CcSEcCtD
Ticagrelor—Headache—Glimepiride—type 2 diabetes mellitus	7.34e-05	0.00075	CcSEcCtD
Ticagrelor—Cough—Irbesartan—type 2 diabetes mellitus	7.33e-05	0.000748	CcSEcCtD
Ticagrelor—Headache—Sitagliptin—type 2 diabetes mellitus	7.32e-05	0.000747	CcSEcCtD
Ticagrelor—Hypertension—Irbesartan—type 2 diabetes mellitus	7.25e-05	0.00074	CcSEcCtD
Ticagrelor—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.24e-05	0.000739	CcSEcCtD
Ticagrelor—Angioedema—Losartan—type 2 diabetes mellitus	7.22e-05	0.000737	CcSEcCtD
Ticagrelor—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.16e-05	0.000731	CcSEcCtD
Ticagrelor—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.15e-05	0.00073	CcSEcCtD
Ticagrelor—Chest pain—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.00073	CcSEcCtD
Ticagrelor—Shock—Metformin—type 2 diabetes mellitus	7.15e-05	0.000729	CcSEcCtD
Ticagrelor—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.12e-05	0.000727	CcSEcCtD
Ticagrelor—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.12e-05	0.000727	CcSEcCtD
Ticagrelor—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.11e-05	0.000726	CcSEcCtD
Ticagrelor—Vertigo—Losartan—type 2 diabetes mellitus	7.1e-05	0.000725	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.1e-05	0.000725	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.1e-05	0.000725	CcSEcCtD
Ticagrelor—Syncope—Losartan—type 2 diabetes mellitus	7.09e-05	0.000723	CcSEcCtD
Ticagrelor—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.08e-05	0.000722	CcSEcCtD
Ticagrelor—Skin disorder—Metformin—type 2 diabetes mellitus	7.06e-05	0.00072	CcSEcCtD
Ticagrelor—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000718	CcSEcCtD
Ticagrelor—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.02e-05	0.000717	CcSEcCtD
Ticagrelor—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.02e-05	0.000716	CcSEcCtD
Ticagrelor—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.99e-05	0.000714	CcSEcCtD
Ticagrelor—Nausea—Glimepiride—type 2 diabetes mellitus	6.96e-05	0.000711	CcSEcCtD
Ticagrelor—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.95e-05	0.000709	CcSEcCtD
Ticagrelor—Nausea—Sitagliptin—type 2 diabetes mellitus	6.94e-05	0.000709	CcSEcCtD
Ticagrelor—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.94e-05	0.000708	CcSEcCtD
Ticagrelor—Asthenia—Glyburide—type 2 diabetes mellitus	6.94e-05	0.000708	CcSEcCtD
Ticagrelor—Cough—Losartan—type 2 diabetes mellitus	6.9e-05	0.000704	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.89e-05	0.000703	CcSEcCtD
Ticagrelor—Fatigue—Valsartan—type 2 diabetes mellitus	6.88e-05	0.000702	CcSEcCtD
Ticagrelor—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.86e-05	0.0007	CcSEcCtD
Ticagrelor—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.86e-05	0.0007	CcSEcCtD
Ticagrelor—Pruritus—Glyburide—type 2 diabetes mellitus	6.84e-05	0.000698	CcSEcCtD
Ticagrelor—Mental disorder—Ramipril—type 2 diabetes mellitus	6.82e-05	0.000696	CcSEcCtD
Ticagrelor—Constipation—Valsartan—type 2 diabetes mellitus	6.82e-05	0.000696	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.8e-05	0.000695	CcSEcCtD
Ticagrelor—Fatigue—Orlistat—type 2 diabetes mellitus	6.8e-05	0.000694	CcSEcCtD
Ticagrelor—Hypotension—Metformin—type 2 diabetes mellitus	6.79e-05	0.000693	CcSEcCtD
Ticagrelor—Malnutrition—Ramipril—type 2 diabetes mellitus	6.78e-05	0.000692	CcSEcCtD
Ticagrelor—Shock—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.000688	CcSEcCtD
Ticagrelor—Chest pain—Losartan—type 2 diabetes mellitus	6.73e-05	0.000687	CcSEcCtD
Ticagrelor—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.72e-05	0.000686	CcSEcCtD
Ticagrelor—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	6.72e-05	0.000686	CcSEcCtD
Ticagrelor—Rash—Bromocriptine—type 2 diabetes mellitus	6.67e-05	0.000681	CcSEcCtD
Ticagrelor—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.66e-05	0.00068	CcSEcCtD
Ticagrelor—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.66e-05	0.00068	CcSEcCtD
Ticagrelor—Headache—Bromocriptine—type 2 diabetes mellitus	6.63e-05	0.000676	CcSEcCtD
Ticagrelor—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.62e-05	0.000675	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.52e-05	0.000666	CcSEcCtD
Ticagrelor—Paraesthesia—Metformin—type 2 diabetes mellitus	6.52e-05	0.000666	CcSEcCtD
Ticagrelor—Confusional state—Losartan—type 2 diabetes mellitus	6.5e-05	0.000664	CcSEcCtD
Ticagrelor—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.49e-05	0.000663	CcSEcCtD
Ticagrelor—Dyspnoea—Metformin—type 2 diabetes mellitus	6.48e-05	0.000661	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.44e-05	0.000658	CcSEcCtD
Ticagrelor—Hypotension—Irbesartan—type 2 diabetes mellitus	6.41e-05	0.000654	CcSEcCtD
Ticagrelor—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.4e-05	0.000653	CcSEcCtD
Ticagrelor—Dyspepsia—Metformin—type 2 diabetes mellitus	6.39e-05	0.000653	CcSEcCtD
Ticagrelor—Shock—Losartan—type 2 diabetes mellitus	6.35e-05	0.000648	CcSEcCtD
Ticagrelor—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.33e-05	0.000646	CcSEcCtD
Ticagrelor—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.31e-05	0.000644	CcSEcCtD
Ticagrelor—Nausea—Bromocriptine—type 2 diabetes mellitus	6.28e-05	0.000641	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.27e-05	0.00064	CcSEcCtD
Ticagrelor—Fatigue—Metformin—type 2 diabetes mellitus	6.26e-05	0.000639	CcSEcCtD
Ticagrelor—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.23e-05	0.000636	CcSEcCtD
Ticagrelor—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.23e-05	0.000636	CcSEcCtD
Ticagrelor—Asthenia—Gliclazide—type 2 diabetes mellitus	6.23e-05	0.000636	CcSEcCtD
Ticagrelor—Constipation—Metformin—type 2 diabetes mellitus	6.21e-05	0.000634	CcSEcCtD
Ticagrelor—Angioedema—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000632	CcSEcCtD
Ticagrelor—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.16e-05	0.000628	CcSEcCtD
Ticagrelor—Vomiting—Glyburide—type 2 diabetes mellitus	6.15e-05	0.000627	CcSEcCtD
Ticagrelor—Pruritus—Gliclazide—type 2 diabetes mellitus	6.14e-05	0.000627	CcSEcCtD
Ticagrelor—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.11e-05	0.000624	CcSEcCtD
Ticagrelor—Rash—Glyburide—type 2 diabetes mellitus	6.1e-05	0.000622	CcSEcCtD
Ticagrelor—Dermatitis—Glyburide—type 2 diabetes mellitus	6.09e-05	0.000622	CcSEcCtD
Ticagrelor—Vertigo—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000622	CcSEcCtD
Ticagrelor—Syncope—Ramipril—type 2 diabetes mellitus	6.08e-05	0.00062	CcSEcCtD
Ticagrelor—Headache—Glyburide—type 2 diabetes mellitus	6.06e-05	0.000618	CcSEcCtD
Ticagrelor—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.03e-05	0.000616	CcSEcCtD
Ticagrelor—Hypotension—Losartan—type 2 diabetes mellitus	6.03e-05	0.000615	CcSEcCtD
Ticagrelor—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.99e-05	0.000611	CcSEcCtD
Ticagrelor—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.96e-05	0.000608	CcSEcCtD
Ticagrelor—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.94e-05	0.000606	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.94e-05	0.000606	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.92e-05	0.000604	CcSEcCtD
Ticagrelor—Cough—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000604	CcSEcCtD
Ticagrelor—Fatigue—Irbesartan—type 2 diabetes mellitus	5.91e-05	0.000603	CcSEcCtD
Ticagrelor—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.88e-05	0.0006	CcSEcCtD
Ticagrelor—Constipation—Irbesartan—type 2 diabetes mellitus	5.86e-05	0.000598	CcSEcCtD
Ticagrelor—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.81e-05	0.000593	CcSEcCtD
Ticagrelor—Paraesthesia—Losartan—type 2 diabetes mellitus	5.79e-05	0.000591	CcSEcCtD
Ticagrelor—Chest pain—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000589	CcSEcCtD
Ticagrelor—Dyspnoea—Losartan—type 2 diabetes mellitus	5.75e-05	0.000587	CcSEcCtD
Ticagrelor—Nausea—Glyburide—type 2 diabetes mellitus	5.74e-05	0.000586	CcSEcCtD
Ticagrelor—Abdominal pain—Metformin—type 2 diabetes mellitus	5.74e-05	0.000586	CcSEcCtD
Ticagrelor—Dizziness—Gliclazide—type 2 diabetes mellitus	5.74e-05	0.000586	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.73e-05	0.000585	CcSEcCtD
Ticagrelor—Asthenia—Valsartan—type 2 diabetes mellitus	5.72e-05	0.000584	CcSEcCtD
Ticagrelor—Dyspepsia—Losartan—type 2 diabetes mellitus	5.68e-05	0.00058	CcSEcCtD
Ticagrelor—Asthenia—Orlistat—type 2 diabetes mellitus	5.65e-05	0.000577	CcSEcCtD
Ticagrelor—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.65e-05	0.000577	CcSEcCtD
Ticagrelor—Pruritus—Valsartan—type 2 diabetes mellitus	5.64e-05	0.000576	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.61e-05	0.000572	CcSEcCtD
Ticagrelor—Confusional state—Ramipril—type 2 diabetes mellitus	5.58e-05	0.000569	CcSEcCtD
Ticagrelor—Pruritus—Orlistat—type 2 diabetes mellitus	5.58e-05	0.000569	CcSEcCtD
Ticagrelor—Fatigue—Losartan—type 2 diabetes mellitus	5.56e-05	0.000568	CcSEcCtD
Ticagrelor—Vomiting—Gliclazide—type 2 diabetes mellitus	5.52e-05	0.000563	CcSEcCtD
Ticagrelor—Constipation—Losartan—type 2 diabetes mellitus	5.52e-05	0.000563	CcSEcCtD
Ticagrelor—Rash—Gliclazide—type 2 diabetes mellitus	5.47e-05	0.000559	CcSEcCtD
Ticagrelor—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.47e-05	0.000558	CcSEcCtD
Ticagrelor—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.46e-05	0.000557	CcSEcCtD
Ticagrelor—Shock—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000555	CcSEcCtD
Ticagrelor—Headache—Gliclazide—type 2 diabetes mellitus	5.44e-05	0.000555	CcSEcCtD
Ticagrelor—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000554	CcSEcCtD
Ticagrelor—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.42e-05	0.000553	CcSEcCtD
Ticagrelor—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.42e-05	0.000553	CcSEcCtD
Ticagrelor—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.39e-05	0.00055	CcSEcCtD
Ticagrelor—Skin disorder—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000548	CcSEcCtD
Ticagrelor—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.32e-05	0.000543	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.28e-05	0.000538	CcSEcCtD
Ticagrelor—Dizziness—Valsartan—type 2 diabetes mellitus	5.27e-05	0.000538	CcSEcCtD
Ticagrelor—Dizziness—Orlistat—type 2 diabetes mellitus	5.21e-05	0.000532	CcSEcCtD
Ticagrelor—Asthenia—Metformin—type 2 diabetes mellitus	5.21e-05	0.000532	CcSEcCtD
Ticagrelor—Hypotension—Ramipril—type 2 diabetes mellitus	5.17e-05	0.000528	CcSEcCtD
Ticagrelor—Nausea—Gliclazide—type 2 diabetes mellitus	5.16e-05	0.000526	CcSEcCtD
Ticagrelor—Pruritus—Metformin—type 2 diabetes mellitus	5.14e-05	0.000525	CcSEcCtD
Ticagrelor—Abdominal pain—Losartan—type 2 diabetes mellitus	5.1e-05	0.00052	CcSEcCtD
Ticagrelor—Body temperature increased—Losartan—type 2 diabetes mellitus	5.1e-05	0.00052	CcSEcCtD
Ticagrelor—Vomiting—Valsartan—type 2 diabetes mellitus	5.07e-05	0.000518	CcSEcCtD
Ticagrelor—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.05e-05	0.000515	CcSEcCtD
Ticagrelor—Rash—Valsartan—type 2 diabetes mellitus	5.03e-05	0.000513	CcSEcCtD
Ticagrelor—Dermatitis—Valsartan—type 2 diabetes mellitus	5.02e-05	0.000513	CcSEcCtD
Ticagrelor—Vomiting—Orlistat—type 2 diabetes mellitus	5.01e-05	0.000511	CcSEcCtD
Ticagrelor—Headache—Valsartan—type 2 diabetes mellitus	5e-05	0.00051	CcSEcCtD
Ticagrelor—Diarrhoea—Metformin—type 2 diabetes mellitus	4.97e-05	0.000507	CcSEcCtD
Ticagrelor—Rash—Orlistat—type 2 diabetes mellitus	4.97e-05	0.000507	CcSEcCtD
Ticagrelor—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.97e-05	0.000507	CcSEcCtD
Ticagrelor—Dermatitis—Orlistat—type 2 diabetes mellitus	4.96e-05	0.000507	CcSEcCtD
Ticagrelor—Headache—Orlistat—type 2 diabetes mellitus	4.94e-05	0.000504	CcSEcCtD
Ticagrelor—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.93e-05	0.000503	CcSEcCtD
Ticagrelor—Asthenia—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.000502	CcSEcCtD
Ticagrelor—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.87e-05	0.000497	CcSEcCtD
Ticagrelor—Pruritus—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.000495	CcSEcCtD
Ticagrelor—Dizziness—Metformin—type 2 diabetes mellitus	4.8e-05	0.00049	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000487	CcSEcCtD
Ticagrelor—Fatigue—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000487	CcSEcCtD
Ticagrelor—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.75e-05	0.000485	CcSEcCtD
Ticagrelor—Nausea—Valsartan—type 2 diabetes mellitus	4.74e-05	0.000484	CcSEcCtD
Ticagrelor—Constipation—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000483	CcSEcCtD
Ticagrelor—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.69e-05	0.000479	CcSEcCtD
Ticagrelor—Nausea—Orlistat—type 2 diabetes mellitus	4.68e-05	0.000478	CcSEcCtD
Ticagrelor—Asthenia—Losartan—type 2 diabetes mellitus	4.63e-05	0.000472	CcSEcCtD
Ticagrelor—Vomiting—Metformin—type 2 diabetes mellitus	4.62e-05	0.000471	CcSEcCtD
Ticagrelor—Rash—Metformin—type 2 diabetes mellitus	4.58e-05	0.000467	CcSEcCtD
Ticagrelor—Dermatitis—Metformin—type 2 diabetes mellitus	4.58e-05	0.000467	CcSEcCtD
Ticagrelor—Pruritus—Losartan—type 2 diabetes mellitus	4.56e-05	0.000466	CcSEcCtD
Ticagrelor—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.56e-05	0.000465	CcSEcCtD
Ticagrelor—Headache—Metformin—type 2 diabetes mellitus	4.55e-05	0.000464	CcSEcCtD
Ticagrelor—Dizziness—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000463	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000462	CcSEcCtD
Ticagrelor—Diarrhoea—Losartan—type 2 diabetes mellitus	4.41e-05	0.000451	CcSEcCtD
Ticagrelor—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.37e-05	0.000446	CcSEcCtD
Ticagrelor—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.37e-05	0.000446	CcSEcCtD
Ticagrelor—Vomiting—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.000445	CcSEcCtD
Ticagrelor—Rash—Irbesartan—type 2 diabetes mellitus	4.32e-05	0.000441	CcSEcCtD
Ticagrelor—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.32e-05	0.000441	CcSEcCtD
Ticagrelor—Nausea—Metformin—type 2 diabetes mellitus	4.31e-05	0.00044	CcSEcCtD
Ticagrelor—Headache—Irbesartan—type 2 diabetes mellitus	4.29e-05	0.000438	CcSEcCtD
Ticagrelor—Dizziness—Losartan—type 2 diabetes mellitus	4.27e-05	0.000435	CcSEcCtD
Ticagrelor—Vomiting—Losartan—type 2 diabetes mellitus	4.1e-05	0.000419	CcSEcCtD
Ticagrelor—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000416	CcSEcCtD
Ticagrelor—Nausea—Irbesartan—type 2 diabetes mellitus	4.07e-05	0.000416	CcSEcCtD
Ticagrelor—Rash—Losartan—type 2 diabetes mellitus	4.07e-05	0.000415	CcSEcCtD
Ticagrelor—Dermatitis—Losartan—type 2 diabetes mellitus	4.06e-05	0.000415	CcSEcCtD
Ticagrelor—Headache—Losartan—type 2 diabetes mellitus	4.04e-05	0.000412	CcSEcCtD
Ticagrelor—Asthenia—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000405	CcSEcCtD
Ticagrelor—Pruritus—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000399	CcSEcCtD
Ticagrelor—Nausea—Losartan—type 2 diabetes mellitus	3.83e-05	0.000391	CcSEcCtD
Ticagrelor—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000386	CcSEcCtD
Ticagrelor—Dizziness—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000373	CcSEcCtD
Ticagrelor—Vomiting—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000359	CcSEcCtD
Ticagrelor—ABCB1—islet of Langerhans—type 2 diabetes mellitus	3.51e-05	0.0323	CbGeAlD
Ticagrelor—CYP3A4—kidney—type 2 diabetes mellitus	3.51e-05	0.0323	CbGeAlD
Ticagrelor—Rash—Ramipril—type 2 diabetes mellitus	3.49e-05	0.000356	CcSEcCtD
Ticagrelor—Dermatitis—Ramipril—type 2 diabetes mellitus	3.48e-05	0.000356	CcSEcCtD
Ticagrelor—Headache—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000354	CcSEcCtD
Ticagrelor—Nausea—Ramipril—type 2 diabetes mellitus	3.29e-05	0.000335	CcSEcCtD
Ticagrelor—ABCB1—retina—type 2 diabetes mellitus	3e-05	0.0276	CbGeAlD
Ticagrelor—ABCB1—nephron tubule—type 2 diabetes mellitus	2.83e-05	0.026	CbGeAlD
Ticagrelor—ABCB1—cardiovascular system—type 2 diabetes mellitus	2.54e-05	0.0233	CbGeAlD
Ticagrelor—ABCB1—kidney—type 2 diabetes mellitus	2.49e-05	0.0228	CbGeAlD
Ticagrelor—ABCB1—pancreas—type 2 diabetes mellitus	2.47e-05	0.0227	CbGeAlD
Ticagrelor—ABCB1—cortex of kidney—type 2 diabetes mellitus	2.42e-05	0.0222	CbGeAlD
Ticagrelor—ABCB1—adipose tissue—type 2 diabetes mellitus	2.24e-05	0.0206	CbGeAlD
Ticagrelor—CYP3A4—liver—type 2 diabetes mellitus	2.22e-05	0.0204	CbGeAlD
Ticagrelor—P2RY12—Hemostasis—TGFB1—type 2 diabetes mellitus	1.75e-05	0.000667	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.71e-05	0.00065	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.7e-05	0.000646	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—BHMT—type 2 diabetes mellitus	1.69e-05	0.000644	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TGFB1—type 2 diabetes mellitus	1.69e-05	0.000641	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.68e-05	0.000638	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.68e-05	0.000638	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.64e-05	0.000624	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.59e-05	0.000604	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TNF—type 2 diabetes mellitus	1.57e-05	0.000599	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.57e-05	0.000598	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.57e-05	0.000598	CbGpPWpGaD
Ticagrelor—ABCB1—liver—type 2 diabetes mellitus	1.57e-05	0.0144	CbGeAlD
Ticagrelor—P2RY12—Signaling Pathways—AVP—type 2 diabetes mellitus	1.55e-05	0.00059	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.55e-05	0.00059	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.55e-05	0.000588	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.54e-05	0.000585	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.52e-05	0.000579	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOB—type 2 diabetes mellitus	1.5e-05	0.00057	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.49e-05	0.000568	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGDS—type 2 diabetes mellitus	1.48e-05	0.000563	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AANAT—type 2 diabetes mellitus	1.48e-05	0.000563	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.48e-05	0.000561	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LPL—type 2 diabetes mellitus	1.43e-05	0.000545	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	1.41e-05	0.000537	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	1.4e-05	0.000533	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	1.4e-05	0.000533	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.4e-05	0.000533	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	1.39e-05	0.000528	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	1.37e-05	0.00052	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.37e-05	0.000519	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	1.35e-05	0.000515	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.35e-05	0.000513	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.34e-05	0.000511	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	1.34e-05	0.000509	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.32e-05	0.000502	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.3e-05	0.000496	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.3e-05	0.000496	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—C3—type 2 diabetes mellitus	1.29e-05	0.00049	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.27e-05	0.000484	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.26e-05	0.000481	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.26e-05	0.000478	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	1.23e-05	0.00047	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	1.23e-05	0.00047	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.23e-05	0.000468	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.23e-05	0.000467	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AGT—type 2 diabetes mellitus	1.23e-05	0.000466	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—AKT1—type 2 diabetes mellitus	1.22e-05	0.000464	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	1.21e-05	0.000461	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.2e-05	0.000458	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LEP—type 2 diabetes mellitus	1.2e-05	0.000457	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOE—type 2 diabetes mellitus	1.2e-05	0.000457	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.19e-05	0.000454	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	1.19e-05	0.000454	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	1.19e-05	0.000454	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	1.19e-05	0.000454	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	1.19e-05	0.000454	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.19e-05	0.000451	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	1.15e-05	0.000439	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	1.15e-05	0.000438	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.13e-05	0.000431	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.11e-05	0.000421	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	1.09e-05	0.000415	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	1.09e-05	0.000415	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.07e-05	0.000407	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.07e-05	0.000406	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	1.06e-05	0.000404	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.06e-05	0.000402	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.04e-05	0.000397	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—INS—type 2 diabetes mellitus	1.03e-05	0.00039	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	1.01e-05	0.000386	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	1.01e-05	0.000386	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	1.01e-05	0.000386	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.01e-05	0.000386	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.01e-05	0.000384	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	9.99e-06	0.00038	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.92e-06	0.000377	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.91e-06	0.000377	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.87e-06	0.000375	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	9.72e-06	0.00037	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	9.72e-06	0.00037	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.42e-06	0.000358	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	9.36e-06	0.000356	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	9.36e-06	0.000356	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	9.3e-06	0.000354	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	9.19e-06	0.00035	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	9.11e-06	0.000347	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	9.11e-06	0.000347	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	9.06e-06	0.000345	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	9.04e-06	0.000344	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	9.04e-06	0.000344	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	9.04e-06	0.000344	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.99e-06	0.000342	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.99e-06	0.000342	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	8.74e-06	0.000332	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	8.7e-06	0.000331	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	8.64e-06	0.000329	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	8.64e-06	0.000329	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	8.62e-06	0.000328	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	8.5e-06	0.000323	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RELA—type 2 diabetes mellitus	8.47e-06	0.000322	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.33e-06	0.000317	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	8.32e-06	0.000316	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	8.24e-06	0.000314	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	8.16e-06	0.00031	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	7.96e-06	0.000303	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	7.79e-06	0.000296	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	7.77e-06	0.000295	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.71e-06	0.000293	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	7.68e-06	0.000292	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	7.68e-06	0.000292	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	7.68e-06	0.000292	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	7.68e-06	0.000292	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.64e-06	0.00029	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	7.61e-06	0.000289	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	7.61e-06	0.000289	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.59e-06	0.000289	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	7.37e-06	0.00028	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	7.35e-06	0.000279	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	7.35e-06	0.000279	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.35e-06	0.000279	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	7.35e-06	0.000279	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	7.35e-06	0.000279	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.22e-06	0.000274	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.14e-06	0.000272	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.12e-06	0.000271	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.03e-06	0.000267	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7e-06	0.000266	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	6.85e-06	0.00026	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	6.72e-06	0.000256	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	6.72e-06	0.000256	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SRC—type 2 diabetes mellitus	6.65e-06	0.000253	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.59e-06	0.000251	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.55e-06	0.000249	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.48e-06	0.000246	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	6.39e-06	0.000243	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	6.26e-06	0.000238	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	6.26e-06	0.000238	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.25e-06	0.000238	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.25e-06	0.000238	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.25e-06	0.000238	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	6.14e-06	0.000234	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	6.1e-06	0.000232	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	6.1e-06	0.000232	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	6.1e-06	0.000232	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	6.07e-06	0.000231	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.99e-06	0.000228	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.99e-06	0.000228	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	5.96e-06	0.000227	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.95e-06	0.000226	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	5.89e-06	0.000224	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.83e-06	0.000222	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	5.78e-06	0.00022	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.77e-06	0.000219	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.77e-06	0.000219	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.66e-06	0.000215	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.57e-06	0.000212	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.57e-06	0.000212	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.57e-06	0.000212	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	5.48e-06	0.000208	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	5.48e-06	0.000208	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	5.48e-06	0.000208	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	5.37e-06	0.000204	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	5.33e-06	0.000203	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.23e-06	0.000199	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.22e-06	0.000199	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.21e-06	0.000198	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	5.01e-06	0.00019	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.95e-06	0.000188	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.95e-06	0.000188	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.9e-06	0.000186	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.83e-06	0.000184	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.75e-06	0.000181	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.75e-06	0.000181	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.73e-06	0.00018	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.73e-06	0.00018	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.73e-06	0.00018	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.73e-06	0.00018	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.54e-06	0.000173	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—type 2 diabetes mellitus	4.48e-06	0.00017	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.22e-06	0.00016	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.13e-06	0.000157	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.09e-06	0.000156	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.09e-06	0.000156	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.07e-06	0.000155	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.02e-06	0.000153	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.94e-06	0.00015	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.9e-06	0.000148	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.86e-06	0.000147	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.86e-06	0.000147	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.8e-06	0.000144	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.78e-06	0.000144	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.76e-06	0.000143	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.76e-06	0.000143	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.76e-06	0.000143	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.74e-06	0.000142	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.73e-06	0.000142	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.67e-06	0.00014	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.65e-06	0.000139	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.63e-06	0.000138	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.63e-06	0.000138	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.54e-06	0.000135	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.5e-06	0.000133	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.37e-06	0.000128	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.37e-06	0.000128	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.37e-06	0.000128	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.35e-06	0.000128	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.31e-06	0.000126	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.29e-06	0.000125	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.28e-06	0.000125	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.21e-06	0.000122	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.19e-06	0.000121	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.13e-06	0.000119	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.12e-06	0.000119	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.09e-06	0.000117	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.09e-06	0.000117	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.05e-06	0.000116	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.05e-06	0.000116	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.92e-06	0.000111	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.92e-06	0.000111	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.72e-06	0.000103	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.67e-06	0.000101	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.52e-06	9.59e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.52e-06	9.59e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.51e-06	9.54e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.48e-06	9.42e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.45e-06	9.3e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.4e-06	9.14e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.34e-06	8.9e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.34e-06	8.9e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.34e-06	8.89e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.3e-06	8.73e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.25e-06	8.55e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.24e-06	8.52e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.18e-06	8.29e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.15e-06	8.19e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.14e-06	8.14e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.07e-06	7.86e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.03e-06	7.71e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.96e-06	7.47e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.93e-06	7.34e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.92e-06	7.32e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.9e-06	7.23e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.68e-06	6.37e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.64e-06	6.25e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.51e-06	5.73e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.44e-06	5.48e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.44e-06	5.48e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.32e-06	5.01e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	4.09e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.63e-07	2.52e-05	CbGpPWpGaD
